Je. Mcelveen et al., Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulins, J CL PATH-M, 53(2), 2000, pp. 77-82
Citations number
24
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Background-A mouse monoclonal antibody (2C7/IgG2b kappa) has been described
recently, which is directed against the major house dust mite allergen Der
p 1, and whose epitope specificity is representative of a major component
of the human IgE anti-Der p 1 response.
Aims-To characterise an anti-idiotypic antibody (2G10/IG1 kappa) raised aga
inst monoclonal antibody 2C7 as surrogate human IgE anti-Der p 1.
Methods-The specificity of the antiidiotype antibody 2G10 was determined by
competitive inhibition experiments using human and mouse immunoglobulins o
f known V-H gene families. The epitope recognised by monoclonal antibody 2G
10 was located on the molecular model of the Fv (fragment variable) region
of monoclonal antibody 2C7.
Results-The data suggest that monoclonal antibody 2G10 is directed against
a crossreactive idiotype on human IgE that is shared by polyclonal IgG. Com
petitive inhibition studies against human immunoglobulins, of globulins, re
presentative of V(H)2, V(H)3, and V(H)4 gene families, showed that monoclon
al antibody 2G10 is mostly likely to be directed against sequences encoded
by either V(H)3 or V(H)4 genes. The fact that monoclonal antibody 2G10 bind
s to the humanised (complementarity determining region (CDR) grafted) CAMPA
TH-1H antibody, but not to the original rat CAMPATH-1 YTH34.5.6 antibody, i
ndicates that it is directed against a framework region rather than the CDR
s. Analysis of amino acids in the V-H region for charge, hydrophobicity, an
d accessibility suggests that reactivity with monoclonal antibody 2G10 is d
efined by a hexapeptide spanning residues 74-79 within framework region 3.
Conclusion-The anti-idiotype monoclonal antibody 2G10 could potentially be
used as a probe for determining the contribution of the V(H)3 and V(H)4 gen
e segments to antigenic specificity.